Form 4: Context Therapeutics Inc.: Chief Legal Officer Acquires Stock Options
SEC Filing Form 4
Alex C. Levit, Chief Legal Officer and Corporate Secretary of Context Therapeutics Inc., acquired stock options for 153,515 shares on March 21, 2024.
Summary
- Alex C. Levit, the Chief Legal Officer and Corporate Secretary of Context Therapeutics Inc., filed a Form 4 on March 22, 2024, reporting a transaction.
- On March 21, 2024, Levit acquired stock options for 153,515 shares of Context Therapeutics Inc. at an exercise price of $1.07.
- These options vest over a four-year period, with 25% vesting on March 21, 2025, and the remainder vesting in equal monthly installments over the subsequent three years, contingent upon continued service with the company.
- Following the reported transaction, Levit directly owns derivative securities for 153,515 shares.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of an insider transaction. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency into the actions of company executives. It is standard practice for officers to receive stock options as part of their compensation packages.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 03/21/2024 | Date of earliest transaction: Alex Levit acquired stock options. |
| 03/21/2025 | 25% of the stock options vest and become exercisable. |
| 03/20/2034 | Expiration date of the stock options. |
| 03/22/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.